http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114807151-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
filingDate 2022-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114807151-B
titleOfInvention Polynucleotide aptamers and combinations thereof for detecting pathogenic microorganisms
abstract The invention discloses a polynucleic acid aptamer for detecting pathogenic microorganisms and a combination thereof, and belongs to the technical field of biological detection. The nucleic acid aptamers and combinations thereof disclosed in the present invention can specifically bind to pathogenic microorganisms, and thus can be used for identification and identification of pathogenic microorganisms. The nucleic acid aptamer of the present invention is screened by using the exponential enrichment ligand system evolution technology. When the nucleic acid aptamer screened by the present invention is used to detect pathogenic microorganisms, it has strong specificity and high sensitivity. In addition, nucleic acid aptamers have the characteristics of small molecular weight, better stability, easy modification, no immunogenicity, and short production cycle. Compared with antibodies, they are more suitable for the detection of pathogenic microorganisms.
priorityDate 2022-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022005048-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111676225-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021202440-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455630621
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD1MEJ0
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7327
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9ZU11

Total number of triples: 30.